Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05701358 · ClinicalTrials.gov registry record · NA

Physiology-guided vs Angiography-guided Non-culprit Lesion Complete Revascularization for Acute MI & Multivessel Disease

A NA study of Coronary Artery Disease and Acute Myocardial Infarction, sponsored by Population Health Research Institute.

Recruiting
Registry status
NA
Development phase
5,100
Enrollment target
20
Study locations

NCT05701358: Recruiting NA study of Coronary Artery Disease and Acute Myocardial Infarction, sponsored by Population Health Research Institute.

NCT05701358 is a NA study of Coronary Artery Disease and Acute Myocardial Infarction that is actively recruiting participants, run by Population Health Research Institute. The registered enrollment target is 5,100 participants, above the 1,264-participant average among 219 other Coronary Artery Disease trials with a reported enrollment target (303% higher). The trial reports 20 study locations across 12 states. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05701358, a NA study of Coronary Artery Disease and Acute Myocardial Infarction, is actively recruiting participants, sponsored by Population Health Research Institute.

RECRUITING
Registry status
NA
Development phase
5,100 participants
Enrollment target
20
Study locations

Study Summary

COMPLETE-2 is a prospective, multi-centre, randomized controlled trial comparing a strategy of physiology-guided complete revascularization to angiography-guided complete revascularization in patients with acute ST-segment elevation myocardial infarction (STEMI) or non-ST-segment elevation myocardial infarction (NSTEMI) and multivessel coronary artery disease (CAD) who have undergone successful culprit lesion Percutaneous Coronary Intervention (PCI). COMPLETE-2 OCT is a large scale, prospective, multi-centre, observational, imaging study of patients with STEMI or NSTEMI and multivessel CAD in a subset of eligible COMPLETE-2 patients.

Conditions Studied

Coronary Artery Disease Acute Myocardial Infarction

Interventions

  • PROCEDURE Physiology-guided NCL PCI
  • PROCEDURE Angiography-guided NCL PCI

Study Locations (20)

Other

  • Klinik Floridsdorf - Vienna
  • William Osler Health System - Brampton
  • University of Alberta Hospital, Mazankowski Heart - Edmonton
  • Hamilton Health Sciences - Hamilton
  • Kingston Health Sciences Centre - Kingston

New York

  • Bassett Medical Center - Cooperstown
  • VA New York Harbor HealthCare System - New York
  • NYU Grossman School of Medicine - New York
  • Montefiore Medical Center - The Bronx

California

  • UCLA - Los Angeles
  • University of California, San Francisco - San Francisco

Kansas

  • Cardiovascular Research Institute of Kansas - Wichita

Maryland

  • The Johns Hopkins University School of Medicine - Baltimore

Michigan

  • University of Michigan - Ann Arbor

Minnesota

  • Metropolitan Cardiology Consultants / Metropolitan Heart and Vascular Institute (MCC/MHVI) - Coon Rapids

New Jersey

  • RWJ Barnabas Health - Jersey City

Trial Details

FieldValue
Enrollment Target 5,100 participants
Start Date 2023-06-22
Est. Completion 2028-06
Phase NA
Population Health Research Institute

21 total trials

What NCT05701358 shows while recruiting

NCT05701358 is an interventional study that assigns participants to a tested intervention. Its 5,100 participants enrollment target places it among the larger protocols in the corpus, above the 1,264-participant average among 219 other Coronary Artery Disease trials with a reported enrollment target (303% higher).

The record links to 2 conditions, with Coronary Artery Disease appearing as the primary indexed condition, and to 2 interventions - of which Physiology-guided NCL PCI is the first listed.

NCT05701358 names 20 study sites across 12 states, led by Other, New York, California.

Frequently Asked Questions

What is clinical trial NCT05701358 about?

NCT05701358 is a clinical study titled "Physiology-guided vs Angiography-guided Non-culprit Lesion Complete Revascularization for Acute MI & Multivessel Disease". COMPLETE-2 is a prospective, multi-centre, randomized controlled trial comparing a strategy of physiology-guided complete revascularization to angiography-guided complete revascularization in patients with acute ST-segment elevation myocardial infarction (STEMI) or non-ST-segment elevation myocardia...

What is the current status of trial NCT05701358?

This trial is currently recruiting. It is a NA study. The enrollment target is 5,100 participants. The study started on 2023-06-22. Estimated completion is 2028-06.

What conditions does trial NCT05701358 study?

This clinical trial studies the following conditions: Coronary Artery Disease, Acute Myocardial Infarction.

What interventions are being tested in trial NCT05701358?

The interventions under investigation include: Physiology-guided NCL PCI (PROCEDURE), Angiography-guided NCL PCI (PROCEDURE).

Who is sponsoring clinical trial NCT05701358?

This trial is sponsored by Population Health Research Institute, which has 21 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05701358 being conducted?

This trial has 20 study locations across California, Kansas, Maryland, Michigan, Minnesota. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Coronary Artery Disease

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT05701358's enrollment target sits among peer trials

5,100 11th of 219 higher than 209 of 219 other Coronary Artery Disease trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Coronary Artery Disease trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT05018611 · 5,100 participants · NA

    Digital Limited Interaction Efficacy Trial of LifeSkills Mobile to Reduce HIV Incidence in YTW

  • NCT06535867 · 5,122 participants

    The Efficacy of Conventional Screening Versus mHealth Screening in Early Detection of Oral Potentially Malignant Disorders and Oral Cancer Amongst the Rural Population of Varanasi: A Prospective and Blinded Study

  • NCT06292078 · 5,076 participants · NA

    Preventing School Exclusion and Opioid Misuse: Effectiveness of the Inclusive Skill-building Learning Approach (ISLA)

  • NCT07037459 · 5,056 participants · Phase 3

    Maridebart Cafraglutide in Heart Failure With Preserved or Mildly Reduced Ejection Fraction and Obesity

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

More recruiting context for NCT05701358

Source: ClinicalTrials.gov NCT05701358, the US trial registry maintained by the National Library of Medicine. NCT05701358 (large enrollment · wide site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.